132 related articles for article (PubMed ID: 10506194)
21. Abnormal regulation of low density lipoprotein-sensitive events in a cholesterol transport mutant.
Dahl NK; Gutheil WG; Liscum L
J Biol Chem; 1993 Aug; 268(23):16979-86. PubMed ID: 8349588
[TBL] [Abstract][Full Text] [Related]
22. Distinct sterol and nonsterol signals for the regulated degradation of 3-hydroxy-3-methylglutaryl-CoA reductase.
Roitelman J; Simoni RD
J Biol Chem; 1992 Dec; 267(35):25264-73. PubMed ID: 1460026
[TBL] [Abstract][Full Text] [Related]
23. 15-substituted lanosterols: post-transcriptional suppressors of 3-hydroxy-3-methylglutaryl coenzyme A reductase.
Anderson JA; Leonard DA; Cusack KP; Frye LL
Arch Biochem Biophys; 1995 Jan; 316(1):190-6. PubMed ID: 7840615
[TBL] [Abstract][Full Text] [Related]
24. Regulation of 3-hydroxy-3-methylglutaryl-CoA reductase mRNA contents in human hepatoma cell line Hep G2 by distinct classes of mevalonate-derived metabolites.
Cohen LH; Griffioen M
Biochem J; 1988 Oct; 255(1):61-7. PubMed ID: 2848511
[TBL] [Abstract][Full Text] [Related]
25. Regulation of cytosolic acetoacetyl coenzyme A thiolase, 3-hydroxy-3-methylglutaryl coenzyme A synthase, 3-hydroxy-3-methylglutaryl coenzyme A reductase, and mevalonate kinase by low density lipoprotein and by 25-hydroxycholesterol in Chinese hamster ovary cells.
Chang TY; Limanek JS
J Biol Chem; 1980 Aug; 255(16):7787-95. PubMed ID: 6105157
[No Abstract] [Full Text] [Related]
26. Regulation of synthesis and degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase by low density lipoprotein and 25-hydroxycholesterol in UT-1 cells.
Faust JR; Luskey KL; Chin DJ; Goldstein JL; Brown MS
Proc Natl Acad Sci U S A; 1982 Sep; 79(17):5205-9. PubMed ID: 6957860
[TBL] [Abstract][Full Text] [Related]
27. Further characterization of a somatic cell mutant defective in regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase.
Peffley D; Miyake J; Leonard S; von Gunten C; Sinensky M
Somat Cell Mol Genet; 1988 Nov; 14(6):527-39. PubMed ID: 2904178
[TBL] [Abstract][Full Text] [Related]
28. Interrelationships between mevalonate metabolism and the mitogenic signaling pathway in T lymphocyte proliferation.
Chakrabarti R; Engleman EG
J Biol Chem; 1991 Jul; 266(19):12216-22. PubMed ID: 1712015
[TBL] [Abstract][Full Text] [Related]
29. Plant-derived monoterpenes suppress hamster kidney cell 3-hydroxy-3-methylglutaryl coenzyme a reductase synthesis at the post-transcriptional level.
Peffley DM; Gayen AK
J Nutr; 2003 Jan; 133(1):38-44. PubMed ID: 12514264
[TBL] [Abstract][Full Text] [Related]
30. Lack of correlation between 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and lovastatin resistance in nerve growth factor treated PC-12 cells.
Marom M; Ben-Baruch G; Roitelman J; Kloog Y
Cell Mol Neurobiol; 1994 Apr; 14(2):119-32. PubMed ID: 7842472
[TBL] [Abstract][Full Text] [Related]
31. Co-ordinate regulation of low-density-lipoprotein receptor and 3-hydroxy-3-methylglutaryl-CoA reductase and synthase gene expression in HepG2 cells.
Molowa DT; Cimis GM
Biochem J; 1989 Jun; 260(3):731-6. PubMed ID: 2569863
[TBL] [Abstract][Full Text] [Related]
32. Effects of compactin, mevalonate and low-density lipoprotein on 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity and low-density-lipoprotein-receptor activity in the human hepatoma cell line Hep G2.
Cohen LH; Griffioen M; Havekes L; Schouten D; van Hinsbergh V; Kempen HJ
Biochem J; 1984 Aug; 222(1):35-9. PubMed ID: 6089762
[TBL] [Abstract][Full Text] [Related]
33. Role of transcription, translation, and protein turnover in controlling the distribution of 3-hydroxy-3-methylglutaryl coenzyme A reductase in the lens.
Cenedella RJ
Invest Ophthalmol Vis Sci; 1995 Sep; 36(10):2133-41. PubMed ID: 7544784
[TBL] [Abstract][Full Text] [Related]
34. Apomine, a novel hypocholesterolemic agent, accelerates degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase and stimulates low density lipoprotein receptor activity.
Roitelman J; Masson D; Avner R; Ammon-Zufferey C; Perez A; Guyon-Gellin Y; Bentzen CL; Niesor EJ
J Biol Chem; 2004 Feb; 279(8):6465-73. PubMed ID: 14627708
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase in vivo by cysteine protease inhibitors.
Inoue S; Bar-Nun S; Roitelman J; Simoni RD
J Biol Chem; 1991 Jul; 266(20):13311-7. PubMed ID: 1906466
[TBL] [Abstract][Full Text] [Related]
36. Mevalonate prevents lovastatin-induced apoptosis in medulloblastoma cell lines.
Wang W; Macaulay RJ
Can J Neurol Sci; 1999 Nov; 26(4):305-10. PubMed ID: 10563217
[TBL] [Abstract][Full Text] [Related]
37. The effect of mevalonate on 3-hydroxy-3-methylglutaryl-CoA reductase activity and the absolute rate of cholesterol biosynthesis in human monocyte-derived macrophages.
Patel DD; Knight BL
Eur J Biochem; 1985 Nov; 153(1):117-23. PubMed ID: 4065145
[TBL] [Abstract][Full Text] [Related]
38. Cell-based screen of HMG-CoA reductase inhibitors and expression regulators using LC-MS.
Gerber R; Ryan JD; Clark DS
Anal Biochem; 2004 Jun; 329(1):28-34. PubMed ID: 15136164
[TBL] [Abstract][Full Text] [Related]
39. Coordinate regulation of 3-hydroxy-3-methylglutaryl-coenzyme A synthase, 3-hydroxy-3-methylglutaryl-coenzyme A reductase, and prenyltransferase synthesis but not degradation in HepG2 cells.
Rosser DS; Ashby MN; Ellis JL; Edwards PA
J Biol Chem; 1989 Jul; 264(21):12653-6. PubMed ID: 2568358
[TBL] [Abstract][Full Text] [Related]
40. Control of cholesterol biosynthesis in Schwann cells.
Fu Q; Goodrum JF; Hayes C; Hostettler JD; Toews AD; Morell P
J Neurochem; 1998 Aug; 71(2):549-55. PubMed ID: 9681444
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
